Atlas Trials

The Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic Syndrome

Clinical trial NCT02093858 · UNKNOWN

Trial details

NCT number
NCT02093858
Sponsor
Central South University
Status
UNKNOWN
Study type
OBSERVATIONAL
SchizophreniaMetabolic Syndrome
Start date
2014-04-01
Primary completion
2017-12-01
Enrollment
212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.